Clinical pregnancy rates affected when serum progesterone levels on day of hcg > 3.5 ng/ ml in patients undergoing IVF, finds research
In vitro fertilization, also called IVF, is a complex series of procedures that can lead to a pregnancy.
Researchers have found in a new study that Clinical pregnancy rates are affected when serum progesterone levels on day of hcg > 3.5 ng/ ml in patients undergoing In vitro fertilization.
The Researchers conducted the research to explore if serum progesterone (P) level on the hCG day has a negative impact on the pregnancy rate in patients undergoing In vitro fertilization with GnRH agonist long protocol. Authors Urman et AL carried out a non-interventional, retrospective study the findings of the which were published in Fertility and Sterility.
In all 2845 In vitro fertilization cycles were performed between 2008-2010 with a GnRH agonist long protocol were included in the study. Pituitary down-regulation was induced with leuprolide acetate. Rec FSH was started on cycle day 3. Ovulation was triggered with rec hCG. E2 and P levels were measured on the hCG day. Decision to proceed with oocyte retrieval was not based on P levels.
Progesterone was significantly correlated with E2 level on the day of hCG, and the number of oocytes collected (p<0.01). Patients with P level up to 3.4 ng/mL had comparable whereas the levels ≥ 3.5ng/mL were associated with significantly reduced clinical pregnancy rates.
These results show that elevated P levels on the hCG day may reduce the success rate of In vitro fertilization in patients undergoing IVF with long protocol. However, study findings indicated that this reduction occurred only after serum P levels exceeded 3.5 ng/mL challenging the previous findings indicating an adverse effect with lower levels.
For further reference log on to: Urman,a,b O. Oktem,a,b E. Alper,b K. Yakin,b S. Aksoy,b R. Mercan.b a Obstetrics and Gynecology, Koc University School of Medicine, Istanbul, Turkey; b Women’s Health Center Assisted Reproduction Unit, American Hospital, Istanbul, Turkey. FertilitySterilty
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.